Article information
Bibliography
Download PDF
Statistics
Tables (12)
TABLE 1. Spanish Hospitals That Provided Data to the National Registry on Implantable Cardioverter Defibrillators in 2006 and Number of Implants Reported by Each Hospital (Grouped According to Autonomous Community and Province)
TABLE 2. Number of Spanish Public Implant Centers According to Autonomous Community in 2006
Figure 1. Total number of implants reported to the registry and estimated by the European Confederation of Medical Suppliers Associations (EUCOMED) from 2002 to 2006. ICD indicates implantable cardioverter defibrillator.
Figure 2. Total number of implants per million population reported to the registry and estimated by the European Confederation of Medical Suppliers Associations (EUCOMED) from 2002 to 2006. ICD indicates implantable cardioverter defibrillator.
TABLE 3. Number of Implants Reported to the Spanish Registry in 2006 According to Autonomous Community and Number of Implants Reported per Million Populationa
TABLE 4. Place of Residence of ICD Implant Patients and Number per Million Population as Reported to the Registry, According to Autonomous Community and Provincea
Figure 4. Left ventricular ejection fraction (LVEF) of the patients in the registry (primary implants and total implants).
Figure 5. New York Heart Association functional class (NYHA FC) of the patients in the registry (primary implants and total implants).
Figure 6. Clinical arrhythmia of the patients in the registry (primary implants and total implants). VF/PVT indicates ventricular fibrillation/paroxysmal ventricular tachycardia; SMVT, sustained monomorphic ventricular tachycardia; NSVT, nonsustained ventricular tachycardia.
Figure 7. Clinical presentation of arrhythmia in the patients of the registry (primary implants and total implants). SCD indicates sudden cardiac death.
TABLE 5. Number of Primary Implants in 2005 and 2006, According to Type of Heart Disease, Clinical Arrhythmia, and Presentation. The Percentages With Respect to Each Type of Heart Disease Appear in Parentheses
Figure 8. Changes in the major indications for implantable cardioverter defibrillators (primary implants) between 2002 and 2006. SCD indicates aborted sudden cardiac death; SMVT, sustained monomorphic ventricular tachycardia; Syncope, syncope without documented electrocardiographic evidence of arrhythmia.
Show moreShow less
Figures (1)
Full text is only aviable in PDF
Bibliography
[1]
Madrid AH, Cinca J, Moro C..
Registro Nacional de Desfibriladores Automáticos Implantables en 1996..
Rev Esp Cardiol, 51 (1998), pp. 349-55
[2]
Peinado R, Arenal A, Arribas F, Torrecilla E, Álvarez M, Ormaetxe J, et al..
Registro Español de Desfibrilador Automático Implantable. Primer Informe Oficial del Grupo de Trabajo de Desfibrilador Implantable de la Sociedad Española de Cardiología (años 2002-2004)..
Rev Esp Cardiol, 58 (2005), pp. 1435-49
[3]
Peinado R, Torrecilla E, Ormaetxe J, Álvarez M..
Registro Español de Desfibrilador Automático Implantable. Segundo Informe Oficial del Grupo de Trabajo de Desfibrilador Implantable de la Sociedad Española de Cardiología (año 2005)..
Rev Esp Cardiol, 59 (2006), pp. 1292-302
[4]
Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al..
Executive summary of the guidelines for the diagnosis and treatment of chronic heart failure: the task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology..
Eur Heart J, 11 (2005), pp. 1115-40
[5]
Hunt SA..
ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association task force on practice guidelines..
J Am Coll Cardiol, 46 (2005), pp. e1-82
[6]
Zipes DP, Camm AJ, Borggrefe M, Buxton M, Chaitman B, Fromer M, et al..
ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death..
J Am Coll Cardiol, 48 (2006), pp. e247-e346
[7]
Implantable cardioverter defibrillator for arrhythmias. Review of technology appraisal 11. Available from: www.nice.org.uk/TA095
[8]
Hammill S, Phurrough S, Brindis R..
The National ICD Registry: Now and into the future..
Heart Rhythm, 3 (2006), pp. 470-3
[9]
Available from: www. pacemaker.dk
[10]
Bonhorst D, Morgado F, Elvas L..
National Registry on Cardiac Electrophysiology 2005..
Rev Port Cardiol, 26 (2007), pp. 77-87
[11]
Fitch-Warner K, García de Yébenes MJ, Lázaro y de Mercado P, Belaza-Santurde J..
Variabilidad entre comunidades autónomas en el uso de tres tecnologías cardiovasculares..
Rev Esp Cardiol, 59 (2006), pp. 1232-43
[12]
López-Palop R, Moreu J, Fernández-Vázquez F, Hernández Antolín R..
Registro Español de Hemodinámica y Cardiología Intervencionista. XV Informe Oficial de la Sección de Hemodinámica y Cardiología Intervencionista de la Sociedad Española de Cardiología (1990-2005)..
Rev Esp Cardiol, 59 (2006), pp. 1146-64
[13]
Proclemer A, Ghidina M, Cicuttini G, Gregori D, Fioretti PM..
The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national actividy during the years 2001-2003..
Ital Heart J, 6 (2005), pp. 272-80
[14]
Parkes J, Chase DL, Grace A, Cunningham D, Roderick PJ..
Inequity of use of implantable cardioverter defibrillators in England: retrospective analysis..
BMJ, 330 (2005), pp. 454-5
[15]
Gómez de la Cámara A..
La medicina basada en evidencias científicas: mito o realidad de la variabilidad de la práctica clínica y de su repercusión en los resultados en salud..
An Sis San Navarra, 25 (2001), pp. 11-26
[16]
Ovsyshcher IE, Furman S..
Determinants of geographic variations in pacemakers and imiplantable cardioverter defibrillators implantation rates..
PACE, 26 (2003), pp. 474-8
